Skip to content
All Updates
- 36. Recall Alert – Medical Devices Declared Substandard by CDL KarachiJuly 14, 2026
- Mandatory Transition from Conventional to Safety Engineered Reuse-Prevention(RUP) Syringes and Restrictions on Manufacture/Import/Sale of Conventional SyringesJuly 10, 2026
- National Pharmacovigilance Cell (NPC), DRAP released a revised draft of Guidelines on National Pharmacovigilance System (Edition 05) seeking comments from stakeholders.July 6, 2026
- Mandatory Transition from Conventional to Safety Engineered Reuse-Prevention(RUP) Syringes and Restrictions on Manufacture/Import/Sale of Conventional SyringesJuly 2, 2026
- Possible Interruption in E-Services due to Internet disruptionJune 29, 2026
- 35. Recall Alert – DTL Punjab Declared Substandard Drug Products.June 18, 2026
- Implementation of Track and Trace System – Amendments in the Drugs (Labelling and Packing) Rules, 1986June 11, 2026
- Notification of Amendments in the Drugs (Labeling and Packing) Rules 1986 (09.06.2026)June 10, 2026
- 34- Recall Alert- DTL Sindh declared Substandard Auto Disable SyringesJune 8, 2026
- 33. Rapid Alert – SPURIOUS DRUG PRODUCTS (NOVIDAT 500MG Tablets and TONOFLEX-P Tablets)June 3, 2026
- Minutes of 358th Meeting of the Registration BoardJune 3, 2026
- 32. Rapid Alert – SPURIOUS / FALSIFIED DANZEN DS TABLETSJune 2, 2026
- 31. Rapid Alert – SPURIOUS / FALSIFIED BREXIN TABLETS 20 mgJune 2, 2026
- 30. Recall Alert – CDL Declared Sub-standard Medical DevicesJune 1, 2026
- 29. Recall Alert – DTL Sindh declared Substandard Auto Disable SyringesMay 22, 2026
- 28. Recall Alert – CDL Karachi declared substandard Auto Disable Syringes.May 22, 2026
- Launch and Implementation of Online Portal for Ethical Marketing to Healthcare Professionals Expenditure Data Submission.May 18, 2026
- Invitation to Bid ( Provisioning of License for Software Appliance Network Firewall – Sophos)May 14, 2026
- Invitation to Bid — Provision of Rental Vehicles with Drivers for DRAP Field Activities at Islamabad, Peshawar, Lahore, Karachi, and QuettaMay 13, 2026
- Launching and Training of Online Systems for Ethical Marketing Data Submission and Appellate Board ApplicationsMay 12, 2026
- Establishment Licences for Import of Medical Devices (MDL&R Portal)May 12, 2026
- Establishment Licenses for Manufacture of Medical Devices (Manually Issued)May 12, 2026
- Final Reminder — Decision of Enlistment Evaluation Committee (EEC) Regarding Pending Enlistment ApplicationsMay 11, 2026
- Implementation of Online System for Therapeutic Goods Advertisement ApplicationsMay 11, 2026
- Implementation of Online System for Appellate Board AppealsMay 9, 2026
- Expression of Interest (Hiring of Legal Consultant)May 7, 2026
- 27. Rapid Alert – Falsified IMFINZI Injection & ENHERTU 100mgMay 6, 2026
- Strategic Plan 2026-2030May 6, 2026
- Minutes of the 356th Meeting of Registration Board (07th April 2026)May 5, 2026
- Decisions of 124th,125th,126th,127th Meeting of Medical Devices Board May 5, 2026
- 26. Recall Alert (Human) – DTLs Punjab declared Substandard productsMay 4, 2026
- 25. Recall Alert (Human) – CDL Declared Substandard products.May 4, 2026
- Career Opportunities in Drug Regulatory Authority of PakistanMay 1, 2026
- Directive on the security of online portals and engagement with authorized personnel/consultantsApril 30, 2026
- Circular for Implementation Plan of PIC/S Guide to Good Manufacturing Practice for Medicinal Products Part-lApril 21, 2026
- Minutes of 355th Meeting of Registration BoardApril 21, 2026
- Minutes of 354th Meeting of Registration BoardApril 21, 2026
- 24. Recall Alert – Veterinary Drug Products declared Substandard by DTL PunjabApril 14, 2026
- 23. Recall Alert – Class II – Drug Products – Provincial reportsApril 14, 2026
- 22. Recall Alert – Drug Products declared substandard by Provincial laboratories.April 14, 2026
- 21. Rapid Alert – SPURIOUS Nandrolone Injection 100mg/mlApril 14, 2026
- 20. Rapid Alert – SPURIOUS DYDROGESTERONE TABLETSApril 14, 2026
- 19. Recall Alert – WHO Recall Class-IIApril 14, 2026
- 18. Rapid Alert – Spurious TERBIDERM FORTE TABLET (TERBINAFINE 250 mg) & GLANTRIM OPHTHALMIC SOLUTIONApril 14, 2026
- Requirements for Grant Of Drug Manufacturing License by the Way of Basic & Semi-Basic Manufacturing for Blood/ Plasma EstablishmentsMarch 30, 2026
- Notification (S.R.O. 515(l)/2026)March 30, 2026
- Invitation to bid (For the supply of chemicals, glassware, reference standards/USP standards/CRMs and columns)March 25, 2026
- Decisions of the 123rd meeting of the Medical Devices Board (MDB) held on 25-02-2026 (Manual Applications Part-II)March 25, 2026
- Tender for Provision of Record Management ServicesMarch 25, 2026
- Draft Therapeutic Goods (Import and Export) Rules 2026 (For Comments)March 18, 2026
